AR and hepatocellular carcinoma: Importantly, mutations (Q62L and E81Q) did not influence the binding of AR to PYGB promoter, but they significantly enhanced the transcriptional activation of AR compared to AR WT in MHCC-97H and HCC-LM3 cells (Fig. 7a–c and Supplementary Fig. 7a–c).